Stalz C. Vilbrun
Port-au-prince, OU, Haiti
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Implementation of differentiated service delivery strategies for patients with tuberculosis in Haiti during a severe humanitarian crisis, January-August 2021.
Journal: PLOS global public health
Published: March 16, 2026
SARS-CoV-2 IgG seropositivity among people living with and without HIV in the first year of the COVID-19 pandemic in Haiti and Tanzania.
Journal: IJID regions
Published: February 20, 2026
Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.
Journal: IJTLD open
Published: October 02, 2024
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 26, 2024
High variance in quantification of Mycobacterium tuberculosis at low bacterial loads and with differentially detectable mycobacteria.
Journal: Antimicrobial agents and chemotherapy
Published: June 03, 2024
Continuity of care during severe civil unrest with a model of community-based HIV care: a retrospective cohort study from Haiti.
Journal: Lancet regional health. Americas
Published: February 23, 2024
Effectiveness of a bedaquiline, linezolid, clofazimine "core" for multidrug-resistant tuberculosis.
Journal: medRxiv : the preprint server for health sciences
Published: January 31, 2024
Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption.
Journal: Science translational medicine
Published: January 17, 2024
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
Journal: Nature communications
Published: September 13, 2023
A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen.
Journal: The Journal of infectious diseases
Published: August 07, 2023
Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2023
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: May 26, 2023
Last Updated: 09/26/2026